Announcements Trials
Browse Landscape

Phase

Phase 1 3Phase 3 2Phase 2 1

Status

Completed 6Unknown 2Recruiting 2Terminated 1

Sponsor Class

INDUSTRY 5OTHER 1

Study Type

Interventional 6

Sponsor

Cancer Type

Gastrointestinal 4Tumor-Agnostic 2Thoracic 1Gynecologic 1Genitourinary 1Dermatologic 1Breast 1

Conditions

Colorectal Neoplasms 63Colonic Neoplasms 29Rectal Neoplasms 25Neoplasm Metastasis 11Stomach Neoplasms 8Carcinoma, Hepatocellular 7Pancreatic Neoplasms 6Neoplasms 6Esophageal Neoplasms 4Adenocarcinoma Of Esophagus 4Liver Neoplasms 3Ovarian Neoplasms 2Esophageal Squamous Cell Carcinoma 2Recurrence 1Prostatic Neoplasms 1Postoperative Complications 1Peritoneal Neoplasms 1Operable T2-3N+M0 Rectal Cancer (Stage III) 1Neuropathy, Painful 1Neuralgia 1Neoplasm Recurrence, Local 1Melanoma 1Malignant Solid Tumour 1Locally Advanced Pancreatic Carcinoma(LAPC) 1Gastrointestinal Neoplasms 1Cold Hypersensitivity 1Cholangiocarcinoma 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1Carcinoma, Basal Cell 1

Interventions

Gemcitabine 109Paclitaxel 92Carboplatin 79Bevacizumab 75pembrolizumab 74Surveys and Questionnaires 70Docetaxel 69Cisplatin 67Nivolumab 48Exercise 48Capecitabine 48Cyclophosphamide 47Sorafenib 43Fluorouracil 43Irinotecan 42Pemetrexed 37Albumin-Bound Paclitaxel 35Radiotherapy 34Dexamethasone 34Blood Specimen Collection 34Oxaliplatin 31Leucovorin 31Erlotinib Hydrochloride 31trametinib 30130-nm albumin-bound paclitaxel 29Cetuximab 28Therapeutics 26Ipilimumab 26Standard of Care 25Methods 25

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Completed × Neoplasms × Folfox protocol × Clear all
NCT02967289 2025-11-17

IROCAS

UNICANCER

Phase 3 Completed
792 enrolled
Gastrointestinal

Colonic Neoplasms, Neoplasms

NCT02009449 2024-11-15

IVY

Eli Lilly and Company

Phase 1 Completed
353 enrolled
BreastDermatologicGastrointestinalGenitourinaryGynecologicThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Colorectal Neoplasms

NCT00364013 2022-11-07

PRIME: Panitumumab Randomized Trial In Combination With Chemotherapy for Metastatic Colorectal Cancer to Determine Efficacy

Amgen

Phase 3 Completed
1,183 enrolled 18 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT02195180 2018-07-27

Efficacy and Safety of L-asparaginase Encapsulated in RBC Combined With Gemcitabine or FOLFOX in 2nd Line for Progressive Metastatic Pancreatic Carcinoma

ERYtech Pharma

Phase 2 Completed
141 enrolled
Tumor-Agnostic

Adenocarcinoma, Neoplasms

NCT00599924 2015-07-15

Study Of Sunitinib Plus FOLFOX In Patients With Solid Tumors

Pfizer

Phase 1 Completed
53 enrolled 31 charts
Gastrointestinal

Neoplasms, Colorectal Neoplasms

NCT00479583 2011-11-30

Combination Trial of BMS-690514 in Combination With FOLFIRI and FOLFOX

Bristol-Myers Squibb

Phase 1 Completed
25 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡